Standout Papers

Fourth universal definition o... 2000 2026 2008 2017 4.1k
  1. Fourth universal definition of myocardial infarction (2018) (2018)
    Kristian Thygesen, Joseph S. Alpert et al. European Heart Journal
  2. Fourth Universal Definition of Myocardial Infarction (2018) (2018)
    Kristian Thygesen, Joseph S. Alpert et al. Journal of the American College of Cardiology
  3. Fourth Universal Definition of Myocardial Infarction (2018) (2018)
    Kristian Thygesen, Joseph S. Alpert et al. Circulation
  4. C-Reactive Protein Levels and Outcomes after Statin Therapy (2005)
    Paul M. Ridker, Christopher P. Cannon et al. New England Journal of Medicine
  5. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation (2000)
    David A. Morrow, Elliott M. Antman et al. Circulation
  6. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes (2001)
    James A. de Lemos, David A. Morrow et al. New England Journal of Medicine
  7. Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population (2010)
    James A. de Lemos, Mark H. Drazner et al. JAMA
  8. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (2018)
    Eric J. Velazquez, David A. Morrow et al. New England Journal of Medicine
  9. Acute Myocardial Infarction (2017)
    Jeffrey L. Anderson, David A. Morrow New England Journal of Medicine
  10. Vorapaxar in the Secondary Prevention of Atherothrombotic Events (2012)
    David A. Morrow, Eugene Braunwald et al. New England Journal of Medicine
  11. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy (1998)
    David A. Morrow, Nader Rifai et al. Journal of the American College of Cardiology
  12. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes (2002)
    Marc S. Sabatine, David A. Morrow et al. Circulation
  13. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014)
    Benjamin M. Scirica, Eugene Braunwald et al. Circulation
  14. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes (2005)
    Marc S. Sabatine, David A. Morrow et al. Circulation
  15. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial (2015)
    Christian T. Ruff, Robert P. Giugliano et al. The Lancet
  16. Fourth Universal Definition of Myocardial Infarction (2018) (2018)
    Kristian Thygesen, Joseph S. Alpert et al. Global Heart
  17. Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury (2019)
    Andrew P. DeFilippis, Andrew R. Chapman et al. Circulation
  18. Cardiogenic Shock After Acute Myocardial Infarction (2021)
    Marc D. Samsky, David A. Morrow et al. JAMA
  19. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure (2023)
    Robert J. Mentz, Jonathan H. Ward et al. Journal of the American College of Cardiology
  20. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation (2025)
    Christian T. Ruff, Siddharth M. Patel et al. New England Journal of Medicine
  21. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock (2025)
    Shashank S. Sinha, David A. Morrow et al. Journal of the American College of Cardiology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 111 standout
Sub-graph 1 of 17

Citing Papers

Supramolecular Adhesive Hydrogels for Tissue Engineering Applications
2022 Standout
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
2021 Standout
14 intermediate papers

Works of David A. Morrow being referenced

Outcomes of Women Compared With Men After Non–ST-Segment Elevation Acute Coronary Syndromes
2019
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease
2004
and 13 more

Author Peers

Author Last Decade Papers Cites
David A. Morrow 28608 12434 8970 579 42.3k
Eugene Braunwald 41820 18050 12184 444 56.1k
Allan S. Jaffe 37677 13311 13469 609 49.8k
James T. Willerson 20757 16670 8075 628 47.0k
Jeffrey L. Anderson 18971 7827 4059 516 34.3k
Kurt Huber 21404 9514 4586 835 32.3k
Harvey D. White 43840 21177 13505 705 56.2k
Frans Van de Werf 30131 12126 9820 746 39.2k
Paul W. Armstrong 27119 9530 7540 843 37.7k
Maarten L. Simoons 24442 10620 9291 351 31.8k
James A. de Lemos 19631 8154 5682 487 30.1k

All Works

Loading papers...

Rankless by CCL
2026